According to Ironwood Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$5.89. In 2022 the company made an earnings per share (EPS) of $1.14 a decrease over its 2021 EPS that were of $3.26.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.89 | -616.67% |
2022 | $1.14 | -65.03% |
2021 | $3.26 | 386.57% |
2020 | $0.67 | 378.57% |
2019 | $0.14 | -107.57% |
2018 | -$1.85 | 131.25% |
2017 | -$0.80 | 42.86% |
2016 | -$0.56 | -44% |
2015 | -$1.00 | -28.06% |
2014 | -$1.39 | -41.6% |
2013 | -$2.38 | 244.93% |
2012 | -$0.69 | 4.55% |
2011 | -$0.66 | 6.45% |
2010 | -$0.62 | -93.8% |
2009 | -$10.00 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
AstraZeneca AZN | $1.98 | -133.70% | ๐ฌ๐ง UK |
Nektar Therapeutics
NKTR | -$1.63 | -72.33% | ๐บ๐ธ USA |